These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 23403888)

  • 1. Effect of ischemia reperfusion injury and epoxyeicosatrienoic acids on caveolin expression in mouse myocardium.
    Chaudhary KR; Cho WJ; Yang F; Samokhvalov V; El-Sikhry HE; Daniel EE; Seubert JM
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):258-63. PubMed ID: 23403888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells.
    Katragadda D; Batchu SN; Cho WJ; Chaudhary KR; Falck JR; Seubert JM
    J Mol Cell Cardiol; 2009 Jun; 46(6):867-75. PubMed ID: 19285984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model.
    Batchu SN; Law E; Brocks DR; Falck JR; Seubert JM
    J Mol Cell Cardiol; 2009 Jan; 46(1):67-74. PubMed ID: 18973759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning.
    Tsutsumi YM; Horikawa YT; Jennings MM; Kidd MW; Niesman IR; Yokoyama U; Head BP; Hagiwara Y; Ishikawa Y; Miyanohara A; Patel PM; Insel PA; Patel HH; Roth DM
    Circulation; 2008 Nov; 118(19):1979-88. PubMed ID: 18936328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel soluble epoxide hydrolase inhibitor protects mitochondrial function following stress.
    Batchu SN; Lee SB; Samokhvalov V; Chaudhary KR; El-Sikhry H; Weldon SM; Seubert JM
    Can J Physiol Pharmacol; 2012 Jun; 90(6):811-23. PubMed ID: 22624559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcolemmal cholesterol and caveolin-3 dependence of cardiac function, ischemic tolerance, and opioidergic cardioprotection.
    See Hoe LE; Schilling JM; Tarbit E; Kiessling CJ; Busija AR; Niesman IR; Du Toit E; Ashton KJ; Roth DM; Headrick JP; Patel HH; Peart JN
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(6):H895-903. PubMed ID: 25063791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helium postconditioning regulates expression of caveolin-1 and -3 and induces RISK pathway activation after ischaemia/reperfusion in cardiac tissue of rats.
    Flick M; Albrecht M; Oei GTML; Steenstra R; Kerindongo RP; Zuurbier CJ; Patel HH; Hollmann MW; Preckel B; Weber NC
    Eur J Pharmacol; 2016 Nov; 791():718-725. PubMed ID: 27742593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exendin-4 ameliorates cardiac ischemia/reperfusion injury via caveolae and caveolins-3.
    Tsutsumi YM; Tsutsumi R; Hamaguchi E; Sakai Y; Kasai A; Ishikawa Y; Yokoyama U; Tanaka K
    Cardiovasc Diabetol; 2014 Sep; 13():132. PubMed ID: 25194961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geranylgeranylacetone protects the heart via caveolae and caveolin-3.
    Tsutsumi YM; Tsutsumi R; Horikawa YT; Sakai Y; Hamaguchi E; Ishikawa Y; Yokoyama U; Kasai A; Kambe N; Tanaka K
    Life Sci; 2014 Apr; 101(1-2):43-8. PubMed ID: 24582814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of cardiac protection from ischemia/reperfusion injury: a role for caveolae and caveolin-1.
    Patel HH; Tsutsumi YM; Head BP; Niesman IR; Jennings M; Horikawa Y; Huang D; Moreno AL; Patel PM; Insel PA; Roth DM
    FASEB J; 2007 May; 21(7):1565-74. PubMed ID: 17272740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway.
    Seubert J; Yang B; Bradbury JA; Graves J; Degraff LM; Gabel S; Gooch R; Foley J; Newman J; Mao L; Rockman HA; Hammock BD; Murphy E; Zeldin DC
    Circ Res; 2004 Sep; 95(5):506-14. PubMed ID: 15256482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolin-1/-3: therapeutic targets for myocardial ischemia/reperfusion injury.
    Yang Y; Ma Z; Hu W; Wang D; Jiang S; Fan C; Di S; Liu D; Sun Y; Yi W
    Basic Res Cardiol; 2016 Jul; 111(4):45. PubMed ID: 27282376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.
    Seubert JM; Sinal CJ; Graves J; DeGraff LM; Bradbury JA; Lee CR; Goralski K; Carey MA; Luria A; Newman JW; Hammock BD; Falck JR; Roberts H; Rockman HA; Murphy E; Zeldin DC
    Circ Res; 2006 Aug; 99(4):442-50. PubMed ID: 16857962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aquaporin-1 in cardiac endothelial cells is downregulated in ischemia, hypoxia and cardioplegia.
    Rutkovskiy A; Bliksøen M; Hillestad V; Amin M; Czibik G; Valen G; Vaage J; Amiry-Moghaddam M; Stensløkken KO
    J Mol Cell Cardiol; 2013 Mar; 56():22-33. PubMed ID: 23238222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of growth plate chondrocytes by 1,25-dihydroxyvitamin D3 requires caveolae and caveolin-1.
    Boyan BD; Wong KL; Wang L; Yao H; Guldberg RE; Drab M; Jo H; Schwartz Z
    J Bone Miner Res; 2006 Oct; 21(10):1637-47. PubMed ID: 16995819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype.
    Park DS; Woodman SE; Schubert W; Cohen AW; Frank PG; Chandra M; Shirani J; Razani B; Tang B; Jelicks LA; Factor SM; Weiss LM; Tanowitz HB; Lisanti MP
    Am J Pathol; 2002 Jun; 160(6):2207-17. PubMed ID: 12057923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of PI3Kα and sarcolemmal ATP-sensitive potassium channels in epoxyeicosatrienoic acid mediated cardioprotection.
    Batchu SN; Chaudhary KR; El-Sikhry H; Yang W; Light PE; Oudit GY; Seubert JM
    J Mol Cell Cardiol; 2012 Jul; 53(1):43-52. PubMed ID: 22561102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury.
    Horikawa YT; Patel HH; Tsutsumi YM; Jennings MM; Kidd MW; Hagiwara Y; Ishikawa Y; Insel PA; Roth DM
    J Mol Cell Cardiol; 2008 Jan; 44(1):123-30. PubMed ID: 18054955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia.
    Edin ML; Hamedani BG; Gruzdev A; Graves JP; Lih FB; Arbes SJ; Singh R; Orjuela Leon AC; Bradbury JA; DeGraff LM; Hoopes SL; Arand M; Zeldin DC
    J Biol Chem; 2018 Mar; 293(9):3281-3292. PubMed ID: 29298899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function.
    Chaudhary KR; Batchu SN; Das D; Suresh MR; Falck JR; Graves JP; Zeldin DC; Seubert JM
    Cardiovasc Res; 2009 Jul; 83(2):362-70. PubMed ID: 19401302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.